Trademark Overview
On Friday, March 14, 2025, a trademark application was filed for SCINTIMUN with the United States Patent and Trademark Office. The USPTO has given the SCINTIMUN trademark a serial number of 79429309. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 7, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The SCINTIMUN trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use